z-logo
open-access-imgOpen Access
Trypanothione Reductase High-Throughput Screening Campaign Identifies Novel Classes of Inhibitors with Antiparasitic Activity
Author(s) -
Georgina A. Holloway,
William N. Charman,
Alan H. Fairlamb,
Reto Brun,
Marcel Kaiser,
Edmund Kostewicz,
Patrizia M. Novello,
John P. Parisot,
J. Henry Richardson,
Ian P. Street,
Keith G. Watson,
Jonathan B. Baell
Publication year - 2009
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01568-08
Subject(s) - antiparasitic , antiparasitic agent , high throughput screening , drug discovery , cytotoxicity , pharmacology , biology , chemistry , computational biology , biochemistry , in vitro , medicine , pathology
High-throughput screening of 100,000 lead-like compounds led to the identification of nine novel chemical classes of trypanothione reductase (TR) inhibitors worthy of further investigation. Hits from five of these chemical classes have been developed further through different combinations of preliminary structure-activity relationship rate probing and assessment of antiparasitic activity, cytotoxicity, and chemical and in vitro metabolic properties. This has led to the identification of novel TR inhibitor chemotypes that are drug-like and display antiparasitic activity. For one class, a series of analogues have displayed a correlation between TR inhibition and antiparasitic activity. This paper explores the process of identifying, investigating, and evaluating a series of hits from a high-throughput screening campaign.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom